AuroMedics Pharma LLC recalls Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx
AuroMedics Pharma recalls single-dose vials of Piperac:illin-Tazobactam injection due to confirmed visible particulate matter (glass) in some units. This may cause serious injury during IV administration. Affected units have specific NDC and lot numbers.
Use caution until it’s fixed
Presence of Particulate Matter: confirmed customer report for presence of visible particulate matter, confirmed as glass
Contact the company & request your remedy
What happened, in plain English
AuroMedics Pharma recalled single-dose vials of Piperacillin-Tazobactam injection for possible glass particles that could cause serious injury during IV use. The recall affects specific batches manufactured in 2018-2019. Read more at govinfonow.com/recall/40581-auromedics-piperacillin-tazobactam-injection-recall-visible-particulate-matter-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/40581-auromedics-piperacillin-tazobactam-injection-recall-visible-particulate-matter-hazard · Updated October 7, 2026 · FDA enforcement record: FDA #D-0926-2018
Cite this page
“AuroMedics Piperacillin-Tazobactam Injection Recall: Visible Particulate Matter Hazard.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40581-auromedics-piperacillin-tazobactam-injection-recall-visible-particulate-matter-hazard. Based on FDA recall #D-0926-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0926-2018%22&limit=1).
Why it’s dangerous
Visible glass particles in the vial can cause serious injury when injected into the bloodstream, such as tissue damage or embolism. This hazard was confirmed by customer reports and testing.
Who’s affected
Healthcare professionals using the injection for intravenous therapy are most at risk. Patients receiving this medication through IV are affected if they use the recalled vials.
How to tell if you have this one
Check for vials labeled 'Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx'. The NDC number is 55150-120-30 with lot numbers PP0317061-A or PP0317049-A.
- Brand
AuroMedics- Category
Drug
What to do — step by step
Check Vial Label
Look for the NDC number 55150-120-30 and lot numbers PP0317061-A or PP0317049-A on the vial.
Questions people ask
Why is this product being recalled?
The recall is due to confirmed customer reports of visible glass particles in some vials, which could cause serious injury during IV administration.
What should I do if I have this product?
Check the vial label for the NDC number 55150-120-30 and lot numbers PP0317061-A or PP0317049-A. If you have these, stop using the vial and contact your healthcare provider.
Is there a remedy for this product?
The recall record does not specify a remedy. Affected users should check the label and contact their healthcare provider.
Contact AuroMedics
We’ve drafted a message you can send AuroMedics to request your refund or repair — edit it as you like.
Subject: Recall D-0926-2018 — AuroMedics AuroMedics Hello, I own a AuroMedics that is covered by recall D-0926-2018 from AuroMedics. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0926-2018 (May 1, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0926-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.